Confrontation naming does not add incremental diagnostic utility in MCI and Alzheimer's disease

Julie A. Testa, Robert J. Ivnik, Bradley F Boeve, Ronald Carl Petersen, Shane V. Pankratz, David S Knopman, Eric George Tangalos, Glenn E. Smith

Research output: Contribution to journalArticle

37 Citations (Scopus)

Abstract

As the incidence of dementia increases, there is a growing need to determine the diagnostic utility of specific neuropsychological tests in the early diagnosis of Alzheimer's disease (AD). In this study, the relative utility of Boston Naming Test (BNT) in the diagnosis of AD was examined and compared to the diagnostic utility of other neuropsychological measures commonly used in the evaluation of AD. Individuals with AD (n = 306), Mild Cognitive Impairment (MCI; n = 67), and cognitively normal subjects (n = 409) with at least 2 annual evaluations were included. Logistic regression analysis suggested that initial BNT impairment is associated with increased risk of subsequent AD diagnosis. However, this risk is significantly less than that imparted by measures of delayed recall impairments. A multivariate Cox proportional hazards regression analysis suggested that BNT impairment imparted no additional risk for subsequent AD diagnosis after delayed recall impairments were included in the model. Although BNT impairment occurred in all severity groups, it was ubiquitous only in moderate to severe dementia. Collectively these results suggest that although BNT impairments become more common as AD progresses, they are neither necessary for the diagnosis of AD nor particularly useful in identifying early AD.

Original languageEnglish (US)
Pages (from-to)504-512
Number of pages9
JournalJournal of the International Neuropsychological Society
Volume10
Issue number4
DOIs
StatePublished - Jul 2004

Fingerprint

Alzheimer Disease
Dementia
Regression Analysis
Neuropsychological Tests
Delayed Diagnosis
Early Diagnosis
Logistic Models
Incidence

Keywords

  • Alzheimer's disease
  • Boston naming test
  • Mild cognitive impairment

ASJC Scopus subject areas

  • Clinical Neurology
  • Neurology
  • Psychiatry and Mental health
  • Neuroscience(all)
  • Psychology(all)

Cite this

Confrontation naming does not add incremental diagnostic utility in MCI and Alzheimer's disease. / Testa, Julie A.; Ivnik, Robert J.; Boeve, Bradley F; Petersen, Ronald Carl; Pankratz, Shane V.; Knopman, David S; Tangalos, Eric George; Smith, Glenn E.

In: Journal of the International Neuropsychological Society, Vol. 10, No. 4, 07.2004, p. 504-512.

Research output: Contribution to journalArticle

@article{d031310f56444ab991662cc5a33d0e24,
title = "Confrontation naming does not add incremental diagnostic utility in MCI and Alzheimer's disease",
abstract = "As the incidence of dementia increases, there is a growing need to determine the diagnostic utility of specific neuropsychological tests in the early diagnosis of Alzheimer's disease (AD). In this study, the relative utility of Boston Naming Test (BNT) in the diagnosis of AD was examined and compared to the diagnostic utility of other neuropsychological measures commonly used in the evaluation of AD. Individuals with AD (n = 306), Mild Cognitive Impairment (MCI; n = 67), and cognitively normal subjects (n = 409) with at least 2 annual evaluations were included. Logistic regression analysis suggested that initial BNT impairment is associated with increased risk of subsequent AD diagnosis. However, this risk is significantly less than that imparted by measures of delayed recall impairments. A multivariate Cox proportional hazards regression analysis suggested that BNT impairment imparted no additional risk for subsequent AD diagnosis after delayed recall impairments were included in the model. Although BNT impairment occurred in all severity groups, it was ubiquitous only in moderate to severe dementia. Collectively these results suggest that although BNT impairments become more common as AD progresses, they are neither necessary for the diagnosis of AD nor particularly useful in identifying early AD.",
keywords = "Alzheimer's disease, Boston naming test, Mild cognitive impairment",
author = "Testa, {Julie A.} and Ivnik, {Robert J.} and Boeve, {Bradley F} and Petersen, {Ronald Carl} and Pankratz, {Shane V.} and Knopman, {David S} and Tangalos, {Eric George} and Smith, {Glenn E.}",
year = "2004",
month = "7",
doi = "10.1017/S1355617704104177",
language = "English (US)",
volume = "10",
pages = "504--512",
journal = "Journal of the International Neuropsychological Society",
issn = "1355-6177",
publisher = "Cambridge University Press",
number = "4",

}

TY - JOUR

T1 - Confrontation naming does not add incremental diagnostic utility in MCI and Alzheimer's disease

AU - Testa, Julie A.

AU - Ivnik, Robert J.

AU - Boeve, Bradley F

AU - Petersen, Ronald Carl

AU - Pankratz, Shane V.

AU - Knopman, David S

AU - Tangalos, Eric George

AU - Smith, Glenn E.

PY - 2004/7

Y1 - 2004/7

N2 - As the incidence of dementia increases, there is a growing need to determine the diagnostic utility of specific neuropsychological tests in the early diagnosis of Alzheimer's disease (AD). In this study, the relative utility of Boston Naming Test (BNT) in the diagnosis of AD was examined and compared to the diagnostic utility of other neuropsychological measures commonly used in the evaluation of AD. Individuals with AD (n = 306), Mild Cognitive Impairment (MCI; n = 67), and cognitively normal subjects (n = 409) with at least 2 annual evaluations were included. Logistic regression analysis suggested that initial BNT impairment is associated with increased risk of subsequent AD diagnosis. However, this risk is significantly less than that imparted by measures of delayed recall impairments. A multivariate Cox proportional hazards regression analysis suggested that BNT impairment imparted no additional risk for subsequent AD diagnosis after delayed recall impairments were included in the model. Although BNT impairment occurred in all severity groups, it was ubiquitous only in moderate to severe dementia. Collectively these results suggest that although BNT impairments become more common as AD progresses, they are neither necessary for the diagnosis of AD nor particularly useful in identifying early AD.

AB - As the incidence of dementia increases, there is a growing need to determine the diagnostic utility of specific neuropsychological tests in the early diagnosis of Alzheimer's disease (AD). In this study, the relative utility of Boston Naming Test (BNT) in the diagnosis of AD was examined and compared to the diagnostic utility of other neuropsychological measures commonly used in the evaluation of AD. Individuals with AD (n = 306), Mild Cognitive Impairment (MCI; n = 67), and cognitively normal subjects (n = 409) with at least 2 annual evaluations were included. Logistic regression analysis suggested that initial BNT impairment is associated with increased risk of subsequent AD diagnosis. However, this risk is significantly less than that imparted by measures of delayed recall impairments. A multivariate Cox proportional hazards regression analysis suggested that BNT impairment imparted no additional risk for subsequent AD diagnosis after delayed recall impairments were included in the model. Although BNT impairment occurred in all severity groups, it was ubiquitous only in moderate to severe dementia. Collectively these results suggest that although BNT impairments become more common as AD progresses, they are neither necessary for the diagnosis of AD nor particularly useful in identifying early AD.

KW - Alzheimer's disease

KW - Boston naming test

KW - Mild cognitive impairment

UR - http://www.scopus.com/inward/record.url?scp=4043114856&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=4043114856&partnerID=8YFLogxK

U2 - 10.1017/S1355617704104177

DO - 10.1017/S1355617704104177

M3 - Article

C2 - 15327729

AN - SCOPUS:4043114856

VL - 10

SP - 504

EP - 512

JO - Journal of the International Neuropsychological Society

JF - Journal of the International Neuropsychological Society

SN - 1355-6177

IS - 4

ER -